Hospitalized COVID patients test Anti-Nausea shot
Disease control
Terminated
This study tested whether adding an injectable form of aprepitant—a medication normally used to prevent nausea—to standard hospital care could help adults recently hospitalized with COVID-19. Researchers wanted to see if it helped patients get discharged sooner and prevented them…
Phase: PHASE2 • Sponsor: Heron Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC